Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this randomized trial is to measure the impact of converting
patients on statin therapy from fenofibrate 160mg to 54mg per day compared to patients who
continue fenofibrate 160mg per day for triglycerides.